Lovely looking monthly chart, but the chartists and traders haves stayed away. Note also the yearly high of 7c. The situation is much better now, with trial nearly complete, good looking data and funding.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025